Esperion Therapeutics, Inc. (ESPR)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-10) · 99.1 | 8-K (2026-01-12) · 99.1 · 99.2 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-05) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-04) · 99.1 | 8-K (2025-01-16) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-12) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-07) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-27) · 99.1 | 8-K (2024-01-11) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-07) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-01) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Condensed Statements of Operations and Comprehensive (loss) Income | — |
|
| Condensed Statements of Operations and Comprehensive Income (loss) | — |
|
| Statements of Operations and Comprehensive Loss | ||
| Statements of Stockholders' Deficit | ||
| Statements of Cash Flows | ||
| Statements of Stockholders' Equity (deficit) | — |
|
| Notes | ||
| Cash Equivalents | ||
| Collaborations With Third Parties | ||
| Commitments and Contingencies | ||
| Convertible Notes | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Employee Benefit Plan | — |
|
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Inventories, Net | ||
| Investments | ||
| Leases | — |
|
| Liability Related To The Revenue Interest Purchase Agreement | ||
| Net (loss) Income Per Common Share | — |
|
| Net Income (loss) Per Common Share | — |
|
| Net Loss Per Common Share | ||
| Other Accrued Liabilities | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | — |
|
| Sale of Future Royalties | ||
| Segment Reporting | ||
| Statements of Cash Flows and Restricted Cash | — |
|
| Stock Compensation | ||
| Stockholders' Deficit | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | ||
| The Company and Basis of Presentation | ||